— Data to be Featured in Oral Presentation at Clinical Trials on Alzheimer’s Disease SEATTLE, WA, USA I October 2, 2019 I Athira Pharma, Inc., a clinical-stage company dedicated to developing first-in-class therapies for Alzheimer’s and...
N-SIDE, provider of innovative software and strategic consulting services, announced that AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials. Within the scope of this agreement, AstraZeneca will use specifically the N-SIDE Supply and...
MONTREAL and CHARLOTTE, N.C., Oct. 3, 2019 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications,...
Veeva SiteVault Free allows sites to manage regulatory documentation and study information for all trials Veeva aims to help industry accelerate clinical research and streamline study start-up and execution across sites and sponsors PLEASANTON, Calif.–(BUSINESS...
An early phase study was conducted in the U.S. in which different combinations of DNA (DNA-HIV-PT123) and protein (AIDSVAX® B/E) vaccines were administered in four randomized treatment groups (T1, T2, T3, T4), to determine which strategy would induce favorable...
Email
Text